For More Information
-
Stephen Paul Mahinka
Partner - Washington, D.C. -
Randall B. Sunberg
Partner - Princeton
Industry Events
Fast Facts
200 partners and counsel focused on the life sciences industry
60 professionals with advanced scientific degrees
800 active life sciences clients
Honors
PLCCross-border Quarterly 2009 Life Sciences Legal Market Review
- Industry Super League - Ranked 16th among law firms worldwide
- Regulatory Super League - Ranked 7th among law firms worldwide
PLCCross-border Life Sciences Handbook 2007/2008
- U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
- England - Recognized for regulatory
- Japan - Recognized for corporate/commercial
Chambers USA 2010: Recommended in Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory
UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology
BioPharm Insight 2010
- Global Legal Advisers to Licensing Agreements: Value - Ranked third
- Global Legal Advisers to Licensing Agreements: Volume - Ranked fourth
- Legal Advisers to North American Licensing Agreements: Value - Ranked third
- Legal Advisers to North American Licensing Agreements: Volume - Ranked third
- Legal Advisers to European Licensing Agreements: Value - Ranked third
- Legal Advisers to European Licensing Agreements: Volume - Ranked fifth
Clients
16 of the top 20 pharmaceutical companies
7 of the top 20 biotechnology companies
12 of the top 20 medical device companies
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Andrew Ruskin
With the passage of the Patient Protection and Affordable Care Act (the Healthcare Reform Law) three months ago, pharmaceutical manufacturers are continuing to assess how the changes to their price-reporting responsibilities are ... more
Outside Publication | Article
Kashmira Makwana
LawFlash/Client Alert | Tax LawFlash
Wendy Unglaub, Gary Wilcox
On May 21, 2010, the U.S. Department of the Treasury (Treasury) issued Notice 2010-45 (the Guidance), which outlines the procedures for obtaining a valuable new 50% tax credit or equivalent cash grant for certain companies in t... more
Presentation | Speech
Stephen Mahinka, Joyce Cowan
Presentation | Webcast
John McAleese, III, J.J. Broderick
Presentation | Speech
Wenseng Pan, Ph.D.
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Scott Memmott, Howard Young
With the passage of the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care Education Reconciliation Act of 2010 (the Healthcare Reform Law), Congress for the first time has mandated that a broad r... more
LawFlash/Client Alert | Tax LawFlash
Wendy Unglaub, Gary Wilcox
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), provides for a valuable new 50% tax credit or equivalent cash grant, fo... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Stephen Mahinka
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), contains provisions supporting the development of comparative effectiven... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen Sanzo, Phoebe Mounts
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), establishes an abbreviated licensure pathway for biosimilar biological p... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen Sanzo
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law, or Law), will have a number of direct and indirect effects on pharmaceutic... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Washington Government Relations and Public Policy Practice
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law, or Law), provides for a number of significant revisions to the existing 34... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Riva Johnson, Saghi Fattahian, Andy Anderson
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), creates a number of immediate issues for employer group health plans. Some o... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
M. Elizabeth Bierman, Michele Buenafe
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), presents a number of new issues for medical device manufacturers. Devic... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Andrew Ruskin, Albert Shay
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), includes substantial changes that will affect how hospitals of all type... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kashmira Makwana, Joyce Cowan
The Patient Protection and Affordable Care Act of 2010 as amended by the Health Care and Education Reconciliation Act of 2010 (Healthcare Reform Law) makes substantial changes to the Medicare Part C Medicare Advantage (MA) and Me... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Michael Ossip, Sarah Andrews
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), includes a provision that requires employers to provide covered employe... more
LawFlash/Client Alert | FDA and Healthcare LawFlash
FDA and Healthcare Practice
The U.S. Food and Drug Administration (FDA or the Agency) recently announced a Proposed Rule titled “Reporting Information Regarding Falsification of Data” in a February 19 Federal Register Notice (75 Fed. Reg. 7,41... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen McDermott, Meredith Auten
The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law), contains more than 32 sections related to healthcare fraud and abuse an... more
LawFlash/Client Alert | Intellectual Property LawFlash
Intellectual Property Practice
On March 29, a U.S. District Court sided with the American Civil Liberties Union (ACLU) and other plaintiffs in an ongoing lawsuit, declaring Myriad Genetics’ patents directed toward nucleotides encoding BRCA genes as inva... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Kathleen McDermott
The Patient Protection and Affordable Care Act of 2010 as amended by the Health Care and Education Reconciliation Act of 2010 (the Healthcare Reform Law) provides for a number of new transparency requirements for several health ... more
LawFlash/Client Alert | Washington Government Relations and Public Policy LawFlash
Washington Government Relations and Public Policy Practice
The Patient Protection and Affordable Care Act (the Healthcare Reform Law) that President Obama signed into law on March 23 contains a large number of provisions that will significantly affect businesses in the coming months and... more
Outside Publication | Article
Stephen Mahinka
LawFlash/Client Alert | Foreign Corrupt Practices Act LawFlash
Amy Conway-Hatcher
On November 12, the Justice Department’s Assistant Attorney General for the Criminal Division, Lanny Breuer, issued a stern warning to the life sciences industry and its executives. As the country wrestles with the challe... more
Presentation | Speech
Emilio Ragosa


